Cooper-Standard Reports Q4 & FY2025 Results, Issues Strong 2026 Adjusted EBITDA Guidance
Summary
Cooper-Standard reported mixed Q4 2025 results but showed full-year operational improvements and issued strong 2026 Adjusted EBITDA guidance, projecting significant margin expansion and future growth from new business awards.
Key Events
-
Mixed Q4 2025 Performance
Sales increased 1.8% year-over-year to $672.4 million, but operating income, net income, and Adjusted EBITDA declined, impacted by customer production disruptions.
-
Improved Full Year 2025 Results
Full year sales were $2.74 billion, with operating income increasing 24% to $86.6 million and net loss significantly improving to $(4.2) million from $(78.7) million in 2024. Adjusted EBITDA grew to $209.7 million.
-
Strong 2026 Adjusted EBITDA Guidance
The company projects 2026 Adjusted EBITDA between $260 million and $300 million, a substantial increase from $209.7 million in 2025, with an expected margin of 10% or more.
-
Significant New Business Awards
Secured $297.9 million in incremental anticipated future annualized sales for 2025, with 74% related to battery electric and full-hybrid vehicle programs and 51% with Chinese OEM customers.
Analysis
Cooper-Standard Holdings Inc. reported mixed fourth-quarter 2025 results, with sales increasing slightly but profitability metrics declining due to customer production disruptions. However, the full year 2025 demonstrated significant operational improvements, including a 24% rise in operating income and a substantial reduction in net loss. The company's outlook for 2026 is notably strong, projecting a significant increase in Adjusted EBITDA to $260-$300 million, with an anticipated margin exceeding 10%. This forward guidance, coupled with nearly $300 million in new business awards for EV/hybrid and Chinese OEM programs, suggests a positive trajectory for future profitability and growth despite recent headwinds.
At the time of this filing, CPS was trading at $37.25 on NYSE in the Manufacturing sector, with a market capitalization of approximately $602.3M. The 52-week trading range was $10.38 to $40.67. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.